Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Murray

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
Antimicrobial Agents and Chemotherapy|December 1, 1978
Comparison of the in vitro activities of HR756 with cephalothin, cefoxitin, and cefamandoleJ P Sosna, P R Murray, G Medoff
Journal of Clinical Microbiology|March 1, 1980
Rapid presumptive identification of anaerobes in blood cultures by gas-liquid chromatographyJ E Sondag, M Ali, P R Murray
The American Review of Respiratory Disease|March 1, 1980
The accuracy of diagnosing pulmonary tuberculosis at a teaching hospitalM Greenbaum, B E Beyt, P R Murray
Antimicrobial Agents and Chemotherapy|March 1, 1979
In vitro activity of HR 756, a new cephalosporin, against Neisseria gonorrhoeaeP R Murray, J L Christman, G Medoff
Annals of Internal Medicine|April 1, 1980
The acid-fast stain: a specific and predictive test for mycobacterial diseaseP R Murray, C Elmore, D J Krogstad
American Journal of Clinical Pathology|June 1, 1979
Theoretic and experimental analysis of the ability of a commercially prepared system to detect mixtures of bacteriaP R Murray, J C Boyd, J W Lewis
Mayo Clinic Proceedings|February 1, 1977
Recovery of group A and nongroup A beta-hemolytic streptococci from throat swab specimensP R Murray, A D Wold, J A Washington
Journal of Clinical Microbiology|July 1, 1996
Contemporary testing for enteric pathogens: the potential for cost, time, and health care savingsA J Morris, P R Murray, L B Reller
Diagnostic Microbiology and Infectious Disease|June 1, 1994
Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected beta-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria. In Vitro Susceptibility Surveillance GroupP R Murray, H F Cantrell, R B Lankford
Journal of Clinical Microbiology|March 1, 1987
Clinical evaluation of three urine screening testsP R Murray, T B Smith, T C McKinney
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Antimicrobial Agents and Chemotherapy|December 1, 1978
Comparison of the in vitro activities of HR756 with cephalothin, cefoxitin, and cefamandoleJ P Sosna, P R Murray, G Medoff
Journal of Clinical Microbiology|March 1, 1980
Rapid presumptive identification of anaerobes in blood cultures by gas-liquid chromatographyJ E Sondag, M Ali, P R Murray
The American Review of Respiratory Disease|March 1, 1980
The accuracy of diagnosing pulmonary tuberculosis at a teaching hospitalM Greenbaum, B E Beyt, P R Murray
Antimicrobial Agents and Chemotherapy|March 1, 1979
In vitro activity of HR 756, a new cephalosporin, against Neisseria gonorrhoeaeP R Murray, J L Christman, G Medoff
Annals of Internal Medicine|April 1, 1980
The acid-fast stain: a specific and predictive test for mycobacterial diseaseP R Murray, C Elmore, D J Krogstad
American Journal of Clinical Pathology|June 1, 1979
Theoretic and experimental analysis of the ability of a commercially prepared system to detect mixtures of bacteriaP R Murray, J C Boyd, J W Lewis
Mayo Clinic Proceedings|February 1, 1977
Recovery of group A and nongroup A beta-hemolytic streptococci from throat swab specimensP R Murray, A D Wold, J A Washington
Journal of Clinical Microbiology|July 1, 1996
Contemporary testing for enteric pathogens: the potential for cost, time, and health care savingsA J Morris, P R Murray, L B Reller
Diagnostic Microbiology and Infectious Disease|June 1, 1994
Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected beta-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria. In Vitro Susceptibility Surveillance GroupP R Murray, H F Cantrell, R B Lankford
Journal of Clinical Microbiology|March 1, 1987
Clinical evaluation of three urine screening testsP R Murray, T B Smith, T C McKinney
Pageof 15